Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Mouse models of cancer.

Cheon DJ, Orsulic S.

Annu Rev Pathol. 2011;6:95-119. doi: 10.1146/annurev.pathol.3.121806.154244. Review.

PMID:
20936938
2.

Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches.

van Miltenburg MH, Jonkers J.

Curr Opin Genet Dev. 2012 Feb;22(1):21-7. doi: 10.1016/j.gde.2012.01.004. Review.

PMID:
22321988
3.

Cancer modeling in the modern era: progress and challenges.

Van Dyke T, Jacks T.

Cell. 2002 Jan 25;108(2):135-44. Review.

4.

Conditional mouse models of cancer.

Vignjevic D, Fre S, Louvard D, Robine S.

Handb Exp Pharmacol. 2007;(178):263-87. Review.

PMID:
17203659
5.

Forty years of cancer modelling in the mouse.

Hirst GL, Balmain A.

Eur J Cancer. 2004 Sep;40(13):1974-80. Review.

PMID:
15315806
6.

Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).

Telang N, Katdare M.

Oncol Rep. 2011 May;25(5):1195-201. doi: 10.3892/or.2011.1215. Review.

PMID:
21399881
7.

Future of early detection of lung cancer: the role of mouse models.

Shaw AT, Kirsch DG, Jacks T.

Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):4999s-5003s. Review.

8.

Technologically advanced cancer modeling in mice.

Tuveson DA, Jacks T.

Curr Opin Genet Dev. 2002 Feb;12(1):105-10. Review.

PMID:
11790563
9.

Transgenic mouse models for tumor suppressor genes.

Palapattu GS, Bao S, Kumar TR, Matzuk MM.

Cancer Detect Prev. 1998;22(1):75-86. Review.

PMID:
9466053
10.

The Mouse Tumor Biology Database: integrated access to mouse cancer biology data.

Krupke D, Näf D, Vincent M, Allio T, Mikaelian I, Sundberg J, Bult C, Eppig J.

Exp Lung Res. 2005 Mar;31(2):259-70. Review.

PMID:
15824024
11.

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.

Mazur PK, Siveke JT.

Gut. 2012 Oct;61(10):1488-500. doi: 10.1136/gutjnl-2011-300756. Review.

PMID:
21873467
12.

Genetically modified mouse models for biomarker discovery and preclinical drug testing.

Kucherlapati R.

Clin Cancer Res. 2012 Feb 1;18(3):625-30. doi: 10.1158/1078-0432.CCR-11-2021.

13.

Transgenic mouse models--a seminal breakthrough in oncogene research.

Smith HW, Muller WJ.

Cold Spring Harb Protoc. 2013 Dec 1;2013(12):1099-108. doi: 10.1101/pdb.top069765. Review.

PMID:
24298026
14.

Mouse models for multistep tumorigenesis.

Wu X, Pandolfi PP.

Trends Cell Biol. 2001 Nov;11(11):S2-9. Review.

PMID:
11684435
15.

Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolism.

Feith DJ.

Methods Mol Biol. 2011;720:129-41. doi: 10.1007/978-1-61779-034-8_7.

PMID:
21318870
16.

Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.

Singh M, Johnson L.

Clin Cancer Res. 2006 Sep 15;12(18):5312-28. Review.

17.

Genetically engineered knock-in and conditional knock-in mouse models of cancer.

Rappaport A, Johnson L.

Cold Spring Harb Protoc. 2014 Sep 2;2014(9):897-911. doi: 10.1101/pdb.top069799. Review.

PMID:
25183823
18.

Modeling cancer in mice.

Jackson-Grusby L.

Oncogene. 2002 Aug 12;21(35):5504-14. Review.

19.

Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies.

Mohammed A, Janakiram NB, Lightfoot S, Gali H, Vibhudutta A, Rao CV.

Curr Med Chem. 2012;19(22):3701-13. Review.

PMID:
22680929
20.

Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.

Pajic M, Scarlett CJ, Chang DK, Sutherland RL, Biankin AV.

Hum Genet. 2011 Jul;130(1):93-101. doi: 10.1007/s00439-011-0990-0. Review.

PMID:
21516344
Items per page

Supplemental Content

Support Center